82
Participants
Start Date
September 30, 2009
Primary Completion Date
February 1, 2014
Study Completion Date
February 1, 2014
eltrombopag
thrombopoietin receptor agonist
Placebo
placebo for comparison
GSK Investigational Site, New York
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Philadelphia
GSK Investigational Site, Durham
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Charlotte
GSK Investigational Site, Jacksonville
GSK Investigational Site, Orlando
GSK Investigational Site, Orlando
GSK Investigational Site, Bordeaux
GSK Investigational Site, Memphis
GSK Investigational Site, Cincinnati
GSK Investigational Site, Barakaldo (Vizcaya)
GSK Investigational Site, Peoria
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Houston
GSK Investigational Site, Phoenix
GSK Investigational Site, Albuquerque
GSK Investigational Site, Orange
GSK Investigational Site, Seattle
GSK Investigational Site, Chicago
GSK Investigational Site, Boston
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Rotterdam
GSK Investigational Site, Barcelona
GSK Investigational Site, Cardiff
GSK Investigational Site, London
GSK Investigational Site, Manchester
GSK Investigational Site, Newcastle upon Tyne
GSK Investigational Site, Southampton
Lead Sponsor
GlaxoSmithKline
INDUSTRY